1-(3-(methyl)-4-(piperidin-1-yl)phenyl)thiourea | 832099-15-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-(3-(methyl)-4-(piperidin-1-yl)phenyl)thiourea
• 英文别名: Thiourea, [3-methyl-4-(1-piperidinyl)phenyl]-；(3-methyl-4-piperidin-1-ylphenyl)thiourea
• CAS: 832099-15-7
• 化学式: C₁₃H₁₉N₃S
• 分子量: 249.38
• InChiKey: NVYVWHZBRGWOSH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  73.4
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• Substituted arylthiourea derivatives useful as inhibitors of viral replication
  申请人：Phadke Avinash

  公开号：US20050032849A1

  公开（公告）日：2005-02-10

  Substituted arylthiourea compounds of Formula I, and the pharmaceutically acceptable salts of such compounds, useful as antiviral agents, are provided herein. Certain substituted arylthioureas disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. Pharmaceutical compositions containing one or more substituted arylthiourea compounds and one or more pharmaceutically acceptable carriers, excipients, or diluents are provided herein. Such pharmaceutical compositions may contain a substituted arylthiourea as the only active agent or may contain a combination of a substituted arylthiourea derivative and one or more other pharmaceutically active agents. Methods of treating Hepatitis C viral infections in mammals are also provided herein.

  本文提供了化合物I的取代芳基硫脲化合物及其药学上可接受的盐，可用作抗病毒剂。本文披露的某些取代芳基硫脲具有强效和/或选择性抑制病毒复制的能力，特别是丙型肝炎病毒复制。本文还提供了含有一种或多种取代芳基硫脲化合物和一种或多种药学上可接受的载体、赋形剂或稀释剂的制药组合物。这种制药组合物可以仅包含一种取代芳基硫脲作为唯一活性剂，也可以包含一种取代芳基硫脲衍生物和一种或多种其他药学活性剂的组合。本文还提供了治疗哺乳动物丙型肝炎病毒感染的方法。
• SUBSTITUTED ARYLTHIOUREA DERIVATIVES USEFUL AS INHIBITORS OF VIRAL REPLICATION
  申请人：Achillion Pharmaceuticals, Inc.

  公开号：EP1648862A2

  公开（公告）日：2006-04-26
• US7718671B2
  申请人：——

  公开号：US7718671B2

  公开（公告）日：2010-05-18
• [EN] SUBSTITUTED ARYLTHIOUREA DERIVATIVES USEFUL AS INHIBITORS OF VIRAL REPLICATION<br/>[FR] DERIVES ARYLTHIO-UREE SUBSTITUES UTILISES EN TANT QU'INHIBITEURS DE LA REPLICATION VIRALE
  申请人：ACHILLION PHARMACEUTICALS INC

  公开号：WO2005007601A2

  公开（公告）日：2005-01-27

  Substituted arylthiourea compounds of Formula I, and the pharmaceutically acceptable salts of such compounds, useful as antiviral agents, are provided herein. Certain substituted arylthioureas disclosed herein are potent and/ or selective inhibitors of viral replication, particularly Hepatitis C virus replication. Pharmaceutical compositions containing one or more substituted arylthiourea compounds and one or more pharmaceutically acceptable carriers, excipients, or diluents are provided herein. Such pharmaceutical compositions may contain a substituted arylthiourea as the only active agent or may contain a combination of a substituted arylthiourea derivative and one or more other pharmaceutically active agents. Methods of treating Hepatitis C viral infections in mammals are also provided herein.